Topic Editors

Animal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman 15462, Kuwait
Animal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman 15462, Kuwait
Animal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman 15462, Kuwait
Laboratorio de Medicina de Conservación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Col. Casco de Santo Tomás, Del. Miguel Hidalgo, Ciudad de México 11340, Mexico

Oxidative Stress and Mitochondrial Dysfunction in Metabolic and Inflammatory Diseases

Abstract submission deadline
closed (8 March 2023)
Manuscript submission deadline
closed (8 July 2023)
Viewed by
20994

Topic Information

Dear Colleagues,

Background Intracellular oxidative stress is induced by the overexpression of reactive oxygen species (ROS) and/or decreased antioxidants defense activity, causing deleterious chemical changes in biomolecules, such as lipids, DNA/RNA, and proteins. ROS are the highly reactive, oxygen-containing, radical or molecular species that include superoxide anion/radical (O2•‒), hydrogen peroxide (H2O2), and hydroxyl radical (HO•). Chemically, ROS are generated from molecular oxygen (O2) during the successive four steps of one electron reduction in mitochondrial respiratory chain. Free radicals (O2•‒/HO•) can further react with organic substrates to form intermediate species and yield the secondary ROS, such as peroxyl radical (RO2•) and hydroperoxide (ROOH). H2O2, which is a relatively less toxic but more stable molecular species, becomes highly toxic after further interaction with Fe++ (Fenton reaction) or in presence of O2•‒ (Haber-Weiss reaction). Scope and information for Authors Obesity triggers the risk of metabolic syndromes including hypertension, type 2 diabetes and related morbidities, such as hypertension, atherosclerosis, NAFLD/NASH, stroke, cardiovascular disease, aging, neurodegenerative diseases, certain types of cancers, and other chronic inflammatory conditions. Over the past years, significant progress has been made toward developing therapeutic strategies, pharmacological interventions, and mitochondria-targeted approaches that reduce oxidative stress and mitochondrial damage and dysfunction and improve mitochondrial quality in disease setting. The purpose of this Special Issue is to highlight the recent advances and progress on the mechanisms of ROS-mediated oxidative stress and mitochondrial dysfunction, as well as novel therapeutic strategies used in metabolic and inflammatory diseases. We, therefore, we welcome original research, review, mini review, and perspective articles on above-mentioned pathophysiological changes in setting of: obesity; diabetes; hypertension; NAFLD/NASH; stroke; atherosclerosis; cardiovascular disease; aging and age-related neurodegenerative diseases; and other chronic inflammatory conditions. Goal About 90% of the endogenous ROS are generated during oxidative phosphorylation in the mitochondria which are the powerhouses to provide energy to cell in the form of ATP molecules, in order to fuel biochemical reactions and support biological functions. In addition to the ATP synthesis and ROS production/scavenging, mitochondria also regulate intracellular Ca2+, apoptotic cell death, and activation of the caspase family of proteases. ROS accumulation, whether from overproduction or as a sequel to defective antioxidant enzymes may lead to the irreversible damage to mitochondria, which may induce or exacerbate pathologies across a wider spectrum of metabolic and inflammatory diseases. The goal is to enhance our understanding how the ROS play out in physiology and pathophysiology, and how the ROS imbalance may influence the cellular or tissue homeostasis and critical cellular processes, such as aerobic/anaerobic respiration, β-oxidation, fatty acid synthesis, protein translation and post-translational modifications, and other modifications driving the genetic/epigenetic landscape reprogramming in metabolic and inflammatory diseases.

Dr. Sardar Sindhu
Dr. Fahd Al-Mulla
Dr. Rasheed Ahmad
Dr. José Antonio Morales-González
Topic Editors

Keywords

  • oxidative stress
  • ROS
  • mitochondrial dysfunction
  • metabolic diseases
  • chronic inflammatory diseases

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Cells
cells
6.0 9.0 2012 16.6 Days CHF 2700
Endocrines
endocrines
- - 2020 27.2 Days CHF 1000
Journal of Molecular Pathology
jmp
- - 2020 24.9 Days CHF 1000
Metabolites
metabolites
4.1 5.3 2011 13.2 Days CHF 2700
Stresses
stresses
- - 2021 17.1 Days CHF 1000
Current Issues in Molecular Biology
cimb
3.1 2.4 1999 13.5 Days CHF 2200

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (7 papers)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
16 pages, 1450 KiB  
Review
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications
by Alfredo Caturano, Margherita D’Angelo, Andrea Mormone, Vincenzo Russo, Maria Pina Mollica, Teresa Salvatore, Raffaele Galiero, Luca Rinaldi, Erica Vetrano, Raffaele Marfella, Marcellino Monda, Antonio Giordano and Ferdinando Carlo Sasso
Curr. Issues Mol. Biol. 2023, 45(8), 6651-6666; https://doi.org/10.3390/cimb45080420 - 12 Aug 2023
Cited by 43 | Viewed by 2623
Abstract
Oxidative stress is a critical factor in the pathogenesis and progression of diabetes and its associated complications. The imbalance between reactive oxygen species (ROS) production and the body’s antioxidant defence mechanisms leads to cellular damage and dysfunction. In diabetes, chronic hyperglycaemia and mitochondrial [...] Read more.
Oxidative stress is a critical factor in the pathogenesis and progression of diabetes and its associated complications. The imbalance between reactive oxygen species (ROS) production and the body’s antioxidant defence mechanisms leads to cellular damage and dysfunction. In diabetes, chronic hyperglycaemia and mitochondrial dysfunction contribute to increased ROS production, further exacerbating oxidative stress. This oxidative burden adversely affects various aspects of diabetes, including impaired beta-cell function and insulin resistance, leading to disrupted glucose regulation. Additionally, oxidative stress-induced damage to blood vessels and impaired endothelial function contribute to the development of diabetic vascular complications such as retinopathy, nephropathy, and cardiovascular diseases. Moreover, organs and tissues throughout the body, including the kidneys, nerves, and eyes, are vulnerable to oxidative stress, resulting in diabetic nephropathy, neuropathy, and retinopathy. Strategies to mitigate oxidative stress in diabetes include antioxidant therapy, lifestyle modifications, and effective management of hyperglycaemia. However, further research is necessary to comprehensively understand the underlying mechanisms of oxidative stress in diabetes and to evaluate the efficacy of antioxidant interventions in preventing and treating diabetic complications. By addressing oxidative stress, it might be possible to alleviate the burden of diabetes and improve patient outcomes. Full article
Show Figures

Figure 1

12 pages, 797 KiB  
Article
Effects of RIPC on the Metabolomical Profile during Lower Limb Digital Subtraction Angiography: A Randomized Controlled Trial
by Karl Kuusik, Teele Kasepalu, Mihkel Zilmer, Jaan Eha, Kaido Paapstel, Kalle Kilk, Aune Rehema and Jaak Kals
Metabolites 2023, 13(7), 856; https://doi.org/10.3390/metabo13070856 - 18 Jul 2023
Cited by 1 | Viewed by 790
Abstract
Remote ischemic preconditioning (RIPC) has demonstrated protective effects in patients with lower extremity arterial disease (LEAD) undergoing digital subtraction angiography (DSA) and/or percutaneous transluminal angioplasty (PTA). This study aimed to investigate the impact of RIPC on the metabolomical profile of LEAD patients undergoing [...] Read more.
Remote ischemic preconditioning (RIPC) has demonstrated protective effects in patients with lower extremity arterial disease (LEAD) undergoing digital subtraction angiography (DSA) and/or percutaneous transluminal angioplasty (PTA). This study aimed to investigate the impact of RIPC on the metabolomical profile of LEAD patients undergoing these procedures and to elucidate its potential underlying mechanisms. A total of 100 LEAD patients were enrolled and randomly assigned to either the RIPC group (n = 46) or the sham group (n = 54). Blood samples were drawn before and 24 h after intervention. Targeted metabolomics analysis was performed using the AbsoluteIDQ p180 Kit, and changes in metabolite concentrations were compared between the groups. The RIPC group demonstrated significantly different dynamics in nine metabolites compared to the sham group, which generally showed a decrease in metabolite concentrations. The impacted metabolites included glutamate, taurine, the arginine-dimethyl-amide-to-arginine ratio, lysoPC a C24:0, lysoPC a C28:0, lysoPC a C26:1, PC aa C38:1, PC ae C30:2, and PC ae C44:3. RIPC exhibited a ‘stabilization’ effect, maintaining metabolite levels amidst ischemia-reperfusion injuries, suggesting its role in enhancing metabolic control. This may improve outcomes for LEAD patients. However, additional studies are needed to definitively establish causal relationships among these metabolic changes. Full article
Show Figures

Figure 1

23 pages, 1235 KiB  
Review
Free Radicals and Obesity-Related Chronic Inflammation Contrasted by Antioxidants: A New Perspective in Coronary Artery Disease
by Carlo Caiati, Alessandro Stanca and Mario Erminio Lepera
Metabolites 2023, 13(6), 712; https://doi.org/10.3390/metabo13060712 - 31 May 2023
Cited by 5 | Viewed by 2341
Abstract
We are surrounded by factors called free radicals (FR), which attach to the molecules our body is made of, first among them the endothelium. Even though FR are to a certain extent a normal factor, nowadays we face an escalating increase in these [...] Read more.
We are surrounded by factors called free radicals (FR), which attach to the molecules our body is made of, first among them the endothelium. Even though FR are to a certain extent a normal factor, nowadays we face an escalating increase in these biologically aggressive molecules. The escalating formation of FR is linked to the increased usage of man-made chemicals for personal care (toothpaste, shampoo, bubble bath, etc.), domestic laundry and dish-washer detergents, and also an ever wider usage of drugs (both prescription and over the counter), especially if they are to be used long-term (years). In addition, tobacco smoking, processed foods, pesticides, various chronic infectious microbes, nutritional deficiencies, lack of sun exposure, and, finally, with a markedly increasing impact, electromagnetic pollution (a terribly destructive factor), can increase the risk of cancer, as well as endothelial dysfunction, owing to the increased production of FR that they cause. All these factors create endothelial damage, but the organism may be able to repair such damage thanks to the intervention of the immune system supported by antioxidants. However, one other factor can perpetuate the state of inflammation, namely obesity and metabolic syndrome with associated hyperinsulinemia. In this review, the role of FR, with a special emphasis on their origin, and of antioxidants, is explored from the perspective of their role in causing atherosclerosis, in particular at the coronary level. Full article
Show Figures

Figure 1

22 pages, 1012 KiB  
Review
Natural Mitochondria Targeting Substances and Their Effect on Cellular Antioxidant System as a Potential Benefit in Mitochondrial Medicine for Prevention and Remediation of Mitochondrial Dysfunctions
by Daniel Schniertshauer, Susanne Wespel and Jörg Bergemann
Curr. Issues Mol. Biol. 2023, 45(5), 3911-3932; https://doi.org/10.3390/cimb45050250 - 02 May 2023
Cited by 1 | Viewed by 3072
Abstract
Based on the knowledge that many diseases are caused by defects in the metabolism of the cells and, in particular, in defects of the mitochondria, mitochondrial medicine starts precisely at this point. This new form of therapy is used in numerous fields of [...] Read more.
Based on the knowledge that many diseases are caused by defects in the metabolism of the cells and, in particular, in defects of the mitochondria, mitochondrial medicine starts precisely at this point. This new form of therapy is used in numerous fields of human medicine and has become a central focus within the field of medicine in recent years. With this form of therapy, the disturbed cellular energy metabolism and an out-of-balance antioxidant system of the patient are to be influenced to a greater extent. The most important tool here is mitotropic substances, with the help of which attempts are made to compensate for existing dysfunction. In this article, both mitotropic substances and accompanying studies showing their efficacy are summarized. It appears that the action of many mitotropic substances is based on two important properties. First, on the property of acting antioxidantly, both directly as antioxidants and via activation of downstream enzymes and signaling pathways of the antioxidant system, and second, via enhanced transport of electrons and protons in the mitochondrial respiratory chain. Full article
Show Figures

Figure 1

12 pages, 2060 KiB  
Article
Elicitation of Inhibitory Effects for AGE-Induced Oxidative Stress in Rotator Cuff-Derived Cells by Apocynin
by Takahiro Furukawa, Takashi Kurosawa, Yutaka Mifune, Atsuyuki Inui, Hanako Nishimoto, Yasuhiro Ueda, Takeshi Kataoka, Kohei Yamaura, Shintaro Mukohara, Tomoya Yoshikawa, Issei Shinohara, Tatsuo Kato, Shuya Tanaka, Masaya Kusunose, Yuichi Hoshino, Takehiko Matsushita and Ryosuke Kuroda
Curr. Issues Mol. Biol. 2023, 45(4), 3434-3445; https://doi.org/10.3390/cimb45040225 - 14 Apr 2023
Cited by 2 | Viewed by 1426
Abstract
Advanced glycation end-products (AGEs) play a critical supportive role during musculoskeletal disorders via glycosylation and oxidative stress. Though apocynin, identified as a potent and selective inhibitor of NADPH oxidase, has been reported to be involved in pathogen-induced reactive oxygen species (ROS), its role [...] Read more.
Advanced glycation end-products (AGEs) play a critical supportive role during musculoskeletal disorders via glycosylation and oxidative stress. Though apocynin, identified as a potent and selective inhibitor of NADPH oxidase, has been reported to be involved in pathogen-induced reactive oxygen species (ROS), its role in age-related rotator cuff degeneration has not been well clarified. Therefore, this study aims to evaluate the in vitro effects of apocynin on human rotator cuff-derived cells. Twelve patients with rotator cuff tears (RCTs) participated in the study. Supraspinatus tendons from patients with RCTs were collected and cultured. After the preparation of RC-derived cells, they were divided into four groups (control group, control + apocynin group, AGEs group, AGEs + apocynin group), and gene marker expression, cell viability, and intracellular ROS production were evaluated. The gene expression of NOX, IL-6, and the receptor for AGEs (RAGE) was significantly decreased by apocynin. We also examined the effect of apocynin in vitro. The results showed that ROS induction and increasing apoptotic cells after treatment of AGEs were significantly decreased, and cell viability increased considerably. These results suggest that apocynin can effectively reduce AGE-induced oxidative stress by inhibiting NOX activation. Thus, apocynin is a potential prodrug in preventing degenerative changes of the rotor cuff. Full article
Show Figures

Figure 1

16 pages, 610 KiB  
Opinion
Rheumatoid Arthritis and Reactive Oxygen Species: A Review
by Naoki Kondo, Tomotake Kanai and Masayasu Okada
Curr. Issues Mol. Biol. 2023, 45(4), 3000-3015; https://doi.org/10.3390/cimb45040197 - 03 Apr 2023
Cited by 4 | Viewed by 3349
Abstract
Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease that causes progressive joint damage and can lead to lifelong disability. Numerous studies support the hypothesis that reactive oxygen species (ROS) are associated with RA pathogenesis. Recent advances have clarified the anti-inflammatory effect of [...] Read more.
Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease that causes progressive joint damage and can lead to lifelong disability. Numerous studies support the hypothesis that reactive oxygen species (ROS) are associated with RA pathogenesis. Recent advances have clarified the anti-inflammatory effect of antioxidants and their roles in RA alleviation. In addition, several important signaling pathway components, such as nuclear factor kappa B, activator-protein-1, nuclear factor (erythroid-derived 2)-like 2/kelch-like associated protein, signal transducer and activator of transcription 3, and mitogen-activated protein kinases, including c-Jun N-terminal kinase, have been identified to be associated with RA. In this paper, we outline the ROS generation process and relevant oxidative markers, thereby providing evidence of the association between oxidative stress and RA pathogenesis. Furthermore, we describe various therapeutic targets in several prominent signaling pathways for improving RA disease activity and its hyper oxidative state. Finally, we reviewed natural foods, phytochemicals, chemical compounds with antioxidant properties and the association of microbiota with RA pathogenesis. Full article
Show Figures

Figure 1

15 pages, 476 KiB  
Article
The Impact of Krebs Cycle Intermediates on the Endocrine System and Immune System: A Comparison
by Borros M. Arneth
Endocrines 2023, 4(1), 179-193; https://doi.org/10.3390/endocrines4010016 - 08 Mar 2023
Cited by 1 | Viewed by 5999
Abstract
Introduction: The Krebs cycle is an important set of reactions that synthesize different molecules and substances that affect various organs. The objective of this paper was to compare the effects of Krebs cycle intermediates on the endocrine system and the immune system. Methods [...] Read more.
Introduction: The Krebs cycle is an important set of reactions that synthesize different molecules and substances that affect various organs. The objective of this paper was to compare the effects of Krebs cycle intermediates on the endocrine system and the immune system. Methods and Materials: The articles used in this paper were obtained from a systematic search of PsycINFO, PubMed, Web of Science, CINAHL, and primary databases. The search terms were “Krebs cycle,” “intermediates,” “endocrine system,” “tricarboxylic acid,” “citric acid cycle,” and “immune system,” and Boolean operators (AND/OR) were used to combine terms. Results: A review of the selected studies showed that Krebs cycle intermediates influence how the endocrine system regulates and controls body processes, including energy uptake. Moreover, these intermediates have both direct and indirect effects on immune function, memory, and activation. Discussion: An understanding of the effects of Krebs cycle intermediates on endocrine and immune processes will provide valuable insights for the development of new therapies. Additionally, this knowledge is a basis for exploring the pathogenesis of the complications related to endocrine system function and for evaluating the immune system response to pathogens. Conclusions: The evidence gathered in this review shows that Krebs cycle intermediates have significant effects on immune and endocrine processes. However, further human and in vivo studies are required to generate additional evidence for the underlying pathways and to identify the potential strategies for targeting these mechanisms to manage specific disorders. Full article
Show Figures

Figure 1

Back to TopTop